On July 22, the Top 100 Series List (2019) in Chinese Pharmaceutical Industry was officially released.

The “Top 100 Series List (2019) in Chinese Pharmaceutical Industry” consists of 5 sub-lists, involving chemical medicine, traditional Chinese medicine, biomedicine, CRO, medical equipment and other fields, and including a total of 260 enterprises.

The top 10 companies in the Top 100 Series List (2019) in Chinese Pharmaceutical Industry are Hengrui Medicine Sino Biopharmaceutical, Shanghai Pharmaceuticals Group, CSPC Group, Qilu Pharmaceutical Group, Fosun Pharma, Hansoh Pharmaceutica, Kelun Pharmaceutical, Joincare and Huadong Medicine.

The top 10 companies of the top 100 Chinese medicine companies in 2019 are Guangzhou Pharmaceutical Group, Buchang Pharmaceuticals, China Resources Sanjiu, Tasly, China Traditional Chinese Medicine, Yunnan Baiyao, Beijing Tongrentang, Jichuan Pharmaceutical, Conba and Yiling Pharmaceutical. 

It is understood that this series directory is evaluated and selected on the basis of the terminal pattern database of three major terminals and six major markets of the Menet website, as well as the innovation power and professional promotion power of pharmaceutical enterprises by the Expert Committee of the Top 100 Chinese Pharmaceutical Industry Rankings organized by the Menet Research Institute.

The total score of the selected company consists of two parts: the first part is the innovation power of the Company, namely the R&D comprehensive index score of R&D investment in 2019, which accounts for 40% of the total score; The second part is the professional promotion power of the company, which is strictly defined by the terminal quantitative data determined by the final selection needs of clinicians and patients in 2019, namely the score of quantitative analysis determined in combination with the terminal data of the three terminals and six major markets of Menet; it accounts for 60 % of the total score.

Let's have a glance 

Top 100 Series List (2019) in Chinese Pharmaceutical Industry 

The figure from Menet 

Source: Saibailan